Our Partners
The EPND Consortium joins public and private leaders in neurodegenerative research and treatment from across Europe to accelerate progress.
The EPND Consortium is made up of 29 public and private partners and will bring together more than 60 separate cohorts to amplify our collective ability to create breakthroughs. With 19 countries currently represented, EPND will build a diverse community of users and contributors in the European Union working to eradicate neurodegenerative diseases.
"Disjointed access to data and samples presents a huge challenge for academia and industry alike. This platform will bring help us in bringing together the community... developing not only a Europe-wide platform but cementing a global reach."
Phil Scordis
Project Co-Leader, UCB
Follow along as our work unfolds
09/05/2024
The EPND biomarker case studies: an interview with Marianna Rizzo and Stephanie Vos
Our latest biomarker research results were presented at AAIC in August, by our Maastricht University...
Read more07/06/2023
EPND partner profile: Charlotte Teunissen
Professor Teunissen is an expert on biomarkers for Alzheimer's disease and multiple sclerosis, leadi...
Read more04/25/2023
EPND partner profile: Michele Hu
An interview with Professor Michele Hu, a leading Parkinson's disease researcher and co-principal in...
Read more11/21/2022
Patient privacy and the GDPR - an interview with Adrian Thorogood
Patient privacy and the GDPR: an EPND interview with Adrian Thorogood...
Read more04/17/2023
An interview with the Spanish Parkinson's Federation, and the EPND Parkinson's Advisory Group
In a special article for Parkinson's awareness month, we speak to the president of the Spanish Parki...
Read more09/21/2022
Patient and caregiver perspectives on research and data sharing: Chris Roberts & Jayne Goodrick
Nothing about us, without all of us: an EPND interview with Chris Roberts and Jayne Goodrick...
Read more12/20/2023
Watch the Biobanking Best Practices and Standard Operating Procedures webinar
This webinar featured presentations of our SOPs and Best Practice guides, to support researchers in ...
Read more11/16/2022
Deliverable 2.1: Data Protection Impact Assessment
Identifying, assessing and addressing privacy risks: the EPND DPIA ...
Read more07/05/2023
Deliverable 3.2: Best practices for biobanking
This report provides guidance on harmonisation and standardisation of biosamples, addressing challen...
Read more
Project Co-Coordinator: Pieter Jelle Visser
Professor of Molecular Epidemiology of Alzheimer's Disease, Department of Psychiatry and Neuropsychology
Project Co-Coordinator: Anthony J. Brookes
Professor of Genomics and Data Science, Department of Genetics and Genome Biology
Project Co-Leader: Phil Scordis
Head of Patient Data Analytics, Data and Translational Sciences
